Desferoxamine preconditioning protects against cerebral ischemia in rats by inducing expressions of hypoxia inducible factor 1α and erythropoietin

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neuroscience Bulletin

• Publication date

  2008-05-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/S12264-008-0089-3PMID 18369388PMCID PMC5552517
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Erythropoietin-Induced Neurovascular Protection, Angiogenesis, and Cerebral Blood Flow Restoration after Focal Ischemia in Mice

  2007cited by this paper
• Delayed administration of deferoxamine reduces brain damage and promotes functional recovery after transient focal cerebral ischemia in the rat

  2006cited by this paper
• [Therapeutic effect of hypoxia-inducible factor-1alpha on focal cerebral ischemia: experiment with rats].

  2006cited by this paper
• Neuroprotection by Hypoxic Preconditioning Involves Oxidative Stress-Mediated Expression of Hypoxia-Inducible Factor and Erythropoietin

  2005cited by this paper
• Mechanisms of Erythropoietin-induced Brain Protection in Neonatal Hypoxia-Ischemia Rat Model

  2004cited by this paper
• The macrosphere model: evaluation of a new stroke model for permanent middle cerebral artery occlusion in rats.

  2003cited by this paper
• Desferrioxamine Induces Delayed Tolerance against Cerebral Ischemia in Vivo and in Vitro

  2002cited by this paper
• Mild Cerebral Ischemia Induces Loss of Cyclin-Dependent Kinase Inhibitors and Activation of Cell Cycle Machinery before Delayed Neuronal Cell Death

  2001cited by this paper
• Therapeutic Benefit of Intravenous Administration of Bone Marrow Stromal Cells After Cerebral Ischemia in Rats

  2001cited by this paper
• Expression of hypoxia-inducible factor-1alpha in the brain of rats during chronic hypoxia.

  2000cited by this paper
• Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress.

  1989cited by this paper
• Reversible middle cerebral artery occlusion without craniectomy in rats.

  1989cited by this paper

• Ferroptosis in ischemic stroke: mechanisms, pathological implications, and therapeutic strategies

  2025cites this paper
• The Janus face of HIF-1α in ischemic stroke and the possible associated pathways.

  2024cites this paper
• The relationship between hypoxia and Alzheimer’s disease: an updated review

  2024cites this paper
• Inhibited hypoxia-inducible factor by intraoperative hyperglycemia increased postoperative delirium of aged patients: A review

  2024cites this paper
• Isoflurane preconditioning induced genomic changes in mouse cortex

  2024cites this paper
• The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and Aging

  2023cites this paper
• Iron, ferroptosis, and ischemic stroke

  2023cites this paper
• Brain Iron Metabolism, Redox Balance and Neurological Diseases

  2023cites this paper
• Ferroptosis: a potential therapeutic target for stroke

  2023cites this paper
• Enriched Environment Attenuates Ferroptosis after Cerebral Ischemia/Reperfusion Injury via the HIF-1α-ACSL4 Pathway

  2023cites this paper
• Tetramethylpyrazine Attenuates Oxygen-glucose Deprivation-induced Neuronal Damage through Inhibition of the HIF-1α/BNIP3 Pathway: From Network Pharmacological Finding to Experimental Validation.

  2023cites this paper
• HIF-1, an important regulator in potential new therapeutic approaches to ischemic stroke.

  2023cites this paper
• Ferroptosis—A Novel Mechanism With Multifaceted Actions on Stroke

  2022influential citation
• SIRT1 mediates hypoxic postconditioning- and resveratrol-induced protection against functional connectivity deficits after subarachnoid hemorrhage

  2022cites this paper
• Desferrioxamine alleviates UHMWPE particle-induced osteoclastic osteolysis by inhibiting caspase-1-dependent pyroptosis in osteocytes

  2022cites this paper
• Activation of HIF-1α/VEGF-A pathway by deferoxamine ameliorates retinal hypoxia in a rat subarachnoid hemorrhage model

  2022cites this paper
• The Molecular Mechanisms of Ferroptosis and Its Role in Blood-Brain Barrier Dysfunction

  2022cites this paper
• Effect of bone morphogenic protein-2 and desferoxamine on distraction osteogenesis.

  2022cites this paper
• L-F001, a Multifunctional Fasudil-Lipoic Acid Dimer Prevents RSL3-Induced Ferroptosis via Maintaining Iron Homeostasis and Inhibiting JNK in HT22 Cells

  2022cites this paper
• Biological Functions and Regulatory Mechanisms of Hypoxia-Inducible Factor-1α in Ischemic Stroke

  2021cites this paper
• Perinatal hypoxic-ischemic damage: review of the current treatment possibilities.

  2021cites this paper
• Targeting Pro-Oxidant Iron with Deferoxamine as a Treatment for Ischemic Stroke: Safety and Optimal Dose Selection in a Randomized Clinical Trial

  2021cites this paper
• Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications

  2021cites this paper
• Iron chelators for acute stroke.

  2020cites this paper
• Microvascular platelet aggregation and thrombosis after subarachnoid hemorrhage: A review and synthesis

  2020cites this paper
• RGD-Modified Nanocarrier-Mediated Targeted Delivery of HIF-1α-AA Plasmid DNA to Cerebrovascular Endothelial Cells for Ischemic Stroke Treatment.

  2019cites this paper
• Rationale and Current Evidence for Testing Iron Chelators for Treating Stroke

  2019cites this paper
• DDAH-1 via HIF-1 target genes improves cerebral ischemic tolerance after hypoxic preconditioning and middle cerebral artery occlusion-reperfusion.

  2019cites this paper
• Reactive Oxygen Species Formation in the Brain at Different Oxygen Levels: The Role of Hypoxia Inducible Factors

  2018cites this paper
• Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1

  2016cites this paper
• Deferoxamine improves antioxidative protection in the brain of neonatal rats: The role of anoxia and body temperature.

  2016cites this paper
• Endogenous Protection in Subarachnoid Hemorrhage

  2015cites this paper
• The effect of deferoxamine on angiogenesis and bone repair in steroid-induced osteonecrosis of rabbit femoral heads

  2015cites this paper
• PKCε-Mediated Arc-Dependent Preconditioning and Aging

  2015cites this paper
• Hypoxia signalling manipulation for bone regeneration

  2015cites this paper
• Comparative Effects of Ischemic Preconditioning and Iron Chelation in Hepatectomy

  2015cites this paper
• Repair of spinal cord injury by hypoxia-inducible factor-1a-expressing neural stem cells

  2014cites this paper
• The Hypoxia-Inducible Factor Pathway, Prolyl Hydroxylase Domain Protein Inhibitors, and Their Roles in Bone Repair and Regeneration

  2014cites this paper
• Piracetam Ameliorated Oxygen and Glucose Deprivation-Induced Injury in Rat Cortical Neurons Via Inhibition of Oxidative Stress, Excitatory Amino Acids Release and P53/Bax

  2014cites this paper
• Erythropoietin Improved Cognitive Function and Decreased Hippocampal Caspase Activity in Rat Pups after Traumatic Brain Injury

  2014cites this paper
• HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice

  2014cites this paper
• How Do Subcellular Organelles Participate in Preconditioning-Conferred Neuroprotection?

  2013cites this paper
• Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by "antioxidant" metal chelators: From ferroptosis to stroke.

  2013cites this paper
• Promise of Neurorestoration and Mitochondrial Biogenesis in Parkinson's Disease with Multi Target Drugs: An Alternative to Stem Cell Therapy

  2013cites this paper
• Decreased Extracellular Adenosine Levels Lead to Loss of Hypoxia-Induced Neuroprotection after Repeated Episodes of Exposure to Hypoxia

  2013cites this paper
• The role of HIF in cobalt-induced ischemic tolerance.

  2013cites this paper
• Hypoxic Preconditioning in the CNS

  2013cites this paper
• Global cerebral ischemia: synaptic and cognitive dysfunction.

  2013cites this paper
• Training the Brain to Survive Stroke

  2012cites this paper
• Iron-Chelating Therapy in Stroke

  2012cites this paper
• Intranasal treatment of neurodegenerative diseases and stroke

  2012cites this paper
• Hypoxia-Inducible Factor: A New Hope to Counteract Stroke

  2012cites this paper
• Hypoxia Inducible Factor-1: Its Potential Role In Cerebral Ischemia

  2012cites this paper
• Effects of novel neuroprotective and neurorestorative multifunctional drugs on iron chelation and glucose metabolism

  2012cites this paper
• Desferrioxamine Attenuates Pancreatic Injury after Major Hepatectomy under Vascular Control of the Liver: Experimental Study in Pigs

  2012cites this paper
• Iron chelators for acute stroke.

  2012cites this paper
• Antioxidant Treatment Attenuates Intestinal Mucosal Damage and Gut Barrier Dysfunction After Major Hepatectomy. Study in a Porcine Model

  2011cites this paper
• Pharmacological Strategies that Affect HIF-1 in the Ischemic Brain: Focus on Hydroxylases Activity and Protein Kinase Pathways

  2011cites this paper
• Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain.

  2011cites this paper
• Deferoxamine preconditioning protects against hypoxia injury in astrocytes: Deferoxamine preconditioning protects against hypoxia injury in astrocytes

  2010cites this paper
• Prolyl Hydroxylase Domain Inhibitors: A Route to HIF Activation and Neuroprotection

  2010cites this paper
• Neuroprotective Multifunctional Iron Chelators: From Redox-Sensitive Process to Novel Therapeutic Opportunities

  2010cites this paper
• Hypoxia‐inducible factor 1: a new hope to counteract neurodegeneration?

  2010cites this paper
• Oxygen sensing: a common crossroad in cancer and neurodegeneration.

  2010cites this paper
• SelectiveInhibitionofHypoxia-InducibleFactor(HIF) Prolyl-Hydroxylase1MediatesNeuroprotectionagainst NormoxicOxidativeDeathviaHIF-andCREB-Independent Pathways

  2009cites this paper
• The construction of siRNA plasmid targeting mouse HIF-1α and in vitro study of its inhibition effect

  2009cites this paper
• Hypoxia Inducible Factor-1 as a Therapeutic Target in Cerebral Ischemia

  2009cites this paper
• DDPH ameliorated oxygen and glucose deprivation-induced injury in rat hippocampal neurons via interrupting Ca2+ overload and glutamate release.

  2009cites this paper
• Selective Inhibition of Hypoxia-Inducible Factor (HIF) Prolyl-Hydroxylase 1 Mediates Neuroprotection against Normoxic Oxidative Death via HIF- and CREB-Independent Pathways

  2009cites this paper
• Intranasal Deferoxamine Provides Increased Brain Exposure and Significant Protection in Rat Ischemic Stroke

  2009cites this paper
• The construction of siRNA plasmid targeting mouse HIF-1α and in vitro study of its inhibition effect

  2009cites this paper